Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001140361-23-000796
Filing Date
2023-01-06
Accepted
2023-01-06 16:09:46
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM PRER14A ny20005635x7_prer14a.htm PRER14A 3692587
2 logo_appleby.jpg GRAPHIC 19244
3 logo_goldmansachs.jpg GRAPHIC 15819
4 logo_innisfree1.jpg GRAPHIC 30972
5 logo_innisfree1x1.jpg GRAPHIC 22857
6 logo_myovantsciences.jpg GRAPHIC 50637
7 logo_myovantsciencesx1.jpg GRAPHIC 46486
  Complete submission text file 0001140361-23-000796.txt   3948861
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: PRER14A | Act: 34 | File No.: 001-37929 | Film No.: 23515157
SIC: 2834 Pharmaceutical Preparations